Factor XI and contact activation as targets for antithrombotic therapy
- 14 May 2015
- journal article
- review article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 13 (8), 1383-1395
- https://doi.org/10.1111/jth.13005
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health awards (HL81326, HL58837, HL101972)
- National Institute of Allergy and Infectious Diseases (AI088937)
- Oregon Clinical and Translational Research Institute (UL1TR000128)
- Oregon National Primate Research Center (RR000163)
This publication has 116 references indexed in Scilit:
- Factor XI-Deficient Mice Display Reduced Inflammation, Coagulopathy, and Bacterial Growth during ListeriosisInfection and Immunity, 2012
- Neutrophil extracellular traps promote deep vein thrombosis in miceJournal of Thrombosis and Haemostasis, 2011
- Factor XII gene mutation in the Hageman familyJournal of Thrombosis and Haemostasis, 2011
- Extracellular DNA traps promote thrombosisProceedings of the National Academy of Sciences of the United States of America, 2010
- Coagulation procofactor activation by factor XIaJournal of Thrombosis and Haemostasis, 2010
- Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In VivoCell, 2009
- Evolution of the contact phase of vertebrate blood coagulationJournal of Thrombosis and Haemostasis, 2008
- Survival Advantage of Coagulation Factor XI–Deficient Mice during Peritoneal SepsisThe Journal of Infectious Diseases, 2008
- Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulationProceedings of the National Academy of Sciences of the United States of America, 2007
- The contact system—a novel branch of innate immunity generating antibacterial peptidesThe EMBO Journal, 2006